Biocon Ltd. reported a profit of Rs 84.5 crore during the second quarter of the financial year 2026, compared to the loss Rs 16 crore in the year-ago period. (Photo: Biocon website) Show Quick Read Summary is AI Generated. Newsroom Reviewed

Biocon Ltd. reported a profit of Rs 84.5 crore during the second quarter of the financial year 2026, compared to the loss of Rs 16 crore in the year-ago period.

The pharma company reported the consolidated top line at Rs 4,296 crore, marking a 19.6% uptick from the revenue of Rs 3,590 crore in the year-ago period, according to an exchange filing on Tuesday.

The Ebitda during this quarter was up 21.9% at Rs 835 crore compared to Rs 685 crore in the year-ago period. Additionally, the margin slightly expanded to 19.4% compared to the 19.1% in the p

See Full Page